---
title: "Anuh Pharma Ltd (ANUHPHR) — Share Price, Financials & Analysis"
symbol: "ANUHPHR"
company: "Anuh Pharma Ltd"
canonical: "https://tapetide.com/stocks/ANUHPHR"
isin: "INE489G01022"
nse_symbol: "ANUHPHR"
bse_code: "506260"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 922.76
generated_at: "2026-09-13T18:50:12.557Z"
---

# Anuh Pharma Ltd (ANUHPHR)

Canonical page: https://tapetide.com/stocks/ANUHPHR

## Company

- **NSE Symbol:** ANUHPHR
- **BSE Code:** 506260
- **ISIN:** INE489G01022
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2008-01-02
- **CEO:** Mr. Ritesh Bipin Shah MBA
- **Employees:** 295
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** anuhpharma.com

## About

Incorporated in 1960,  Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals[1]

## Latest Price

- **Price:** ₹94.86
- **Change:** +3.65 (+4%)
- **Open:** ₹91.2
- **Day High:** ₹95.88
- **Day Low:** ₹90.79
- **Previous Close:** ₹91.21
- **Volume:** 222204
- **As Of:** 2026-09-11T10:23:28+00:00

## Key Fundamentals

Observed at 2026-09-11T04:40:57.597334Z.

- **Market Cap:** ₹922.76 Cr
- **Classification:** Microcap
- **P/E (reported):** 20.7
- **P/E (TTM):** 21.51
- **EPS (TTM):** ₹4.41
- **Book Value:** ₹35.14
- **Price to Book:** 2.6
- **Dividend Yield:** 1.64%
- **ROE:** 11.65%
- **ROCE:** 15.43%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹776 Cr
- **Net Income:** ₹41 Cr
- **EBITDA:** ₹66.1 Cr
- **52-Week High:** ₹99.5
- **52-Week Low:** ₹67
- **RSI (14):** 64.73

## Tapetide Score

- **Score:** 53 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Falling
- **Percentile:** 61 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 70.98 | 9% |
| growth | 35.94 | 9% |
| momentum | 39.52 | 12% |
| ownership | 45.87 | 24% |
| quality | 46.9 | 22% |
| valuation | 73.56 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 24.4%

### Weaknesses

- Company has a low return on equity of 13.8% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -108.11% | -123.28% | -110.43% |
| ebitda margin growth | 4.3% | -18.88% | -35.73% | -19.57% |
| net income growth | -2.56% | -13.5% | 3% | 10% |
| revenue growth | -1.99% | 15.65% | 14% | 12% |
| roce | — | -17.84% | -42.53% | 19.83% |
| roe | — | -19.77% | 15.6% | -18.53% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 150 | 172 | 164 | 138 | 166 | 160 | 198 | 186 | 186 | 197 | 202 | 194 |
| Expenses | 132 | 148 | 145 | 127 | 149 | 145 | 179 | 176 | 174 | 178 | 182 | 178 |
| Operating Profit | 18 | 24 | 19 | 11 | 17 | 15 | 19 | 10 | 12 | 19 | 20 | 16 |
| OPM % | 12 | 14 | 12 | 8 | 10 | 9 | 9 | 6 | 6 | 10 | 10 | 8 |
| Other Income | 2 | 4 | 3 | 4 | 3 | 1 | 1 | 3 | 1 | 2 | -1 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 |
| Profit before tax | 18 | 25 | 20 | 12 | 18 | 13 | 17 | 11 | 10 | 18 | 16 | 17 |
| Tax % | 23 | 24 | 22 | 22 | 17 | 22 | 28 | 24 | 23 | 25 | 25 | 32 |
| Net Profit | 14 | 19 | 15 | 10 | 15 | 10 | 12 | 8 | 8 | 13 | 12 | 11 |
| EPS in Rs | 1.38 | 1.91 | 1.53 | 0.95 | 1.5 | 1.03 | 1.24 | 0.83 | 0.76 | 1.34 | 1.17 | 1.14 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 238 | 321 | 307 | 432 | 487 | 527 | 647 | 662 | 772 | 779 |
| Expenses | 220 | 291 | 284 | 387 | 439 | 476 | 571 | 600 | 709 | 712 |
| Operating Profit | 18 | 30 | 23 | 45 | 47 | 52 | 76 | 62 | 62 | 67 |
| OPM % | 8 | 9 | 8 | 10 | 10 | 10 | 12 | 9 | 8 | 9 |
| Other Income | 7 | 5 | 4 | 11 | 5 | 6 | 12 | 9 | 4 | 5 |
| Interest | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 2 | 2 | 7 | 15 | 12 | 10 | 9 | 9 | 11 | 11 |
| Profit before tax | 23 | 32 | 19 | 39 | 39 | 47 | 78 | 61 | 54 | 60 |
| Tax % | 29 | 28 | 25 | 26 | 22 | 24 | 23 | 22 | 24 | — |
| Net Profit | 17 | 23 | 14 | 28 | 31 | 36 | 60 | 47 | 41 | 44 |
| EPS in Rs | 1.65 | 2.33 | 1.43 | 2.84 | 3.05 | 3.61 | 5.99 | 4.73 | 4.1 | 4.41 |
| Dividend Payout % | 42 | 29 | 48 | 26 | 29 | 28 | 21 | 16 | 37 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 13 | 13 | 13 | 13 | 25 | 25 | 25 | 25 | 25 | 50 |
| Reserves | 128 | 137 | 152 | 150 | 166 | 189 | 216 | 266 | 301 | 302 |
| Borrowings | 0 | 2 | 4 | 45 | 14 | 4 | 1 | 3 | 11 | 0 |
| Other Liabilities | 48 | 57 | 71 | 119 | 128 | 129 | 163 | 152 | 170 | 205 |
| Total Liabilities | 189 | 209 | 240 | 326 | 333 | 347 | 405 | 446 | 507 | 557 |
| Fixed Assets | 17 | 17 | 21 | 84 | 71 | 61 | 53 | 49 | 58 | 57 |
| CWIP | 0 | 6 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 70 | 66 | 39 | 80 | 31 | 43 | 91 | 97 | 106 | 84 |
| Other Assets | 101 | 120 | 147 | 163 | 230 | 243 | 261 | 300 | 342 | 416 |
| Total Assets | 189 | 209 | 240 | 326 | 333 | 347 | 405 | 446 | 507 | 557 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 26 | 2 | 7 | 49 | -19 | 29 | 54 | 13 | 37 | -3 |
| Cash from Investing Activity | -20 | 2 | 3 | -77 | 52 | -8 | -43 | 1 | -20 | 18 |
| Cash from Financing Activity | -4 | -5 | -7 | 22 | -33 | -19 | -12 | -9 | -5 | -26 |
| Net Cash Flow | 2 | -1 | 3 | -5 | 0 | 2 | -2 | 5 | 12 | -12 |
| Free Cash Flow | 25 | -5 | -22 | 13 | -25 | 27 | 52 | 8 | 17 | -11 |
| CFO/OP | 149 | 49 | 56 | 232 | -20 | 80 | 130 | 42 | 78 | 16 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 100 | 109 | 85 | 96 | 90 | 102 | 118 | 107 | 119 | 113 |
| Inventory Days | 72 | 64 | 64 | 98 | 90 | 77 | 66 | 57 | 54 | 90 |
| Days Payable | 102 | 105 | 89 | 166 | 133 | 117 | 139 | 105 | 115 | 114 |
| Cash Conversion Cycle | 70 | 68 | 61 | 28 | 48 | 62 | 46 | 58 | 59 | 89 |
| Working Capital Days | 79 | 80 | 65 | -10 | 57 | 68 | 61 | 69 | 68 | 92 |
| ROCE % | 19 | 14 | 19 | 10 | 16 | 18 | 19 | 26 | 17 | 15 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 70.59% | 69.94% | 69.92% | 69.92% | 69.92% | 69.92% | 69.92% | 69.92% | 71.82% | 71.82% | 71.8% | 71.8% |
| FIIs | 0% | 0% | 0.03% | 0.03% | 0.02% | 0.02% | 0.04% | 0.04% | 0% | 0% | 0.05% | 0.01% |
| DIIs | 0% | 0% | 0.11% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 25.79% | 26.14% | 26.2% | 26.3% | 26.27% | 26.02% | 25.92% | 25.89% | 23.86% | 23.74% | 23.57% | 23.49% |
| Others | 3.61% | 3.92% | 3.75% | 3.75% | 3.79% | 4.04% | 4.13% | 4.16% | 4.33% | 4.44% | 4.59% | 4.71% |
| No. of Shareholders | 19066 | 20519 | 22237 | 23494 | 23910 | 24048 | 24235 | 24257 | 28250 | 27889 | 27425 | 27484 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 6 / 0

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 87.18 | Buy |
| EMA (10) | 88.84 | Buy |
| SMA (20) | 82.67 | Buy |
| EMA (20) | 85.14 | Buy |
| SMA (50) | 80.57 | Buy |
| EMA (50) | 81.74 | Buy |
| SMA (100) | 79.89 | Buy |
| EMA (100) | 80.37 | Buy |
| SMA (200) | 78.57 | Buy |
| EMA (200) | 80.87 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 68.8 | Neutral |
| MACD (12,26,9) | 3.87 | Buy |
| Stochastic (14,3,3) | 77.4 | Neutral |
| ADX (14) | 28.39 | Buy |
| Williams %R (14) | -20.62 | Neutral |
| ATR (14) | 4.14 | High Volatility |
| ROC (12) | 20.05 | Buy |
| Stoch RSI (14) | 67.83 | Neutral |
| UO (7,14,28) | 52.02 | Neutral |

## Filings & Documents

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4aa00906-4097-4d25-8089-9e8cd0fa08dc.pdf) |
| 2026-05-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12d4726e-a854-4b35-9126-b199259cfd4c.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db22e9a2-e45f-47cc-8e49-a8896830b1b5.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cd8b518-8788-471a-9560-fd08aa047c87.pdf) |
| 2025-08-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0fa3838-c22a-4161-a752-fd07d6dfeea1.pdf) |
| 2025-05-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d24cdc7-ab86-4104-8bd6-4542bd315f0c.pdf) |
| 2024-11-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f259f5b3-39f4-4e71-bcd0-c8625d4cfd9e.pdf) |
| 2024-02-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=755e16c4-f9ee-4d98-a151-12ca400c144e.pdf) |
| 2023-08-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9146a94c-6b49-4f23-b104-2656ef250427.pdf) |
| 2023-06-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adf6c347-e68a-427a-89ea-0a98fd957196.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3f59fa0-1c33-4bd4-a158-2acf5c9ad1ab.pdf) |
| 2026-08-14 | [Announcement Under Regulation 30 - General Updates](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=225153b4-5f93-408e-9c13-7d6c2f95fe63.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03c2a3f7-ba4b-490b-b8b4-daf22f36938b.pdf) |
| 2026-08-12 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=683b11ba-8c0b-4bcc-9533-6f459099d3a6.pdf) |
| 2026-08-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1eb89991-6310-46a0-9d3d-d7a18b5c35c0.pdf) |
| 2026-08-07 | [Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/08/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c865baa-c50b-49b1-bef2-af8eba572b95.pdf) |
| 2026-08-07 | [Announcement Under Regulation 30 (LODR) - Intimation Regarding The Request Received For Withdrawal Of Application For Reclassification.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5c8645d-34bb-4c06-8b96-88e83aa31f6a.pdf) |
| 2026-08-07 | [Announcement Under Regulation 30 (LODR) - Adoption Of Revised Policy Of Related Party Transactions](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d49e3205-f115-42fc-b883-1105e0449e92.pdf) |
| 2026-08-03 | [Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a560d3e-af32-4ce0-b993-d817e843e556.pdf) |
| 2026-07-18 | [Shareholder Meeting - Annual General Meeting On Wednesday 12Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a370d6e-0129-45c2-9f6f-98d6327691e7.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Results - Financial Results For June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf454222-c9fe-4be1-9555-56c8cc98677a.pdf) |
| 2026-05-20 | [Results - Financials Results For The Year Ended 31/03/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7b3b183-9238-477c-91a7-35035b0f3af3.pdf) |
| 2026-02-06 | [Results-Financial Results For December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd82a7c8-7072-4b9c-9487-b8bbd502ad57.pdf) |
| 2025-11-07 | [Results-Financial Results For September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c877560-ad45-4116-81f1-5be0ad72b1bb.pdf) |
| 2025-08-08 | [Results-Financial Results For June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91f17f6e-9c19-410d-b1d3-7ca6d21e056a.pdf) |
| 2025-05-23 | [Results - Financials Results For The Year Ended 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27b8ae44-5952-4478-a901-24e49efd8700.pdf) |
| 2025-05-23 | [Revised Results - Financial Results For March 31 2025 (Quarter And Year Ended 31/03/2025)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e4ca45b-0d9a-49b2-bcb3-01269799dcc1.pdf) |
| 2025-02-07 | [Results - Financial Results For December 31 2024 (Quarter Ended 31St December 2024)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7f39d8d-1e6b-4316-8da2-f41c61cf0f4e.pdf) |
| 2024-11-08 | [Results - Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4617e7e6-9a5c-4b5c-bd4a-63dc76251b29.pdf) |
| 2024-08-09 | [Results - Financial Results June 30, 2024 (Quarter Ended)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a511d49f-05c4-404f-af5f-ee4fc3e39cab.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Feb - Newspaper publication of the Un-Audited financial results for the Quarter ended 31st December, 2025, published in the Financial Express in English Language and Mumbai Lakshdeep … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Feb - Newspaper publication of the Un-Audited financial results for the Quarter ended 31st December, 2025, published in the Financial Express in English Language and Mumbai Lakshdeep …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d843de4c-9797-424d-9914-1c98ba7f867b.pdf) |
| 7 Apr - Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026 received from Bigshare Services Private … | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026 received from Bigshare Services Private …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f13338a9-a69f-4529-a2a3-22acfbf4e51f.pdf) |
| 6 Mar - EDQM audited Tarapur facilities (E-17/3, E-17/4, E-18); found compliant on 06-Mar-2026. | [Announcement Under Regulation 30 (LODR) - Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) Audit And Our Facilities Were Found Compliant Under The Audit. 6 Mar - EDQM audited Tarapur facilities (E-17/3, E-17/4, E-18); found compliant on 06-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/414cae8b-70bf-40bc-89df-d17f43fe12cf.pdf) |
| 6 Feb - Anuh Pharma's Tarapur facilities inspected by USFDA; inspection completed with no Form 483 observations. | [Announcement Under Regulation 30 (LODR) - Completion Of United States Food And Drug Administration (USFDA) Inspection With No Form 483 Observations Issued 6 Feb - Anuh Pharma's Tarapur facilities inspected by USFDA; inspection completed with no Form 483 observations.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1e41ffca-dc76-48d8-986d-8a5d6634ef8a.pdf) |
| 4 May - Anuh Pharma received WHO prequalification for Amodiaquine Hydrochloride USP API on 04 May 2026. | [Announcement Under Regulation 30 (LODR) - Updates 4 May - Anuh Pharma received WHO prequalification for Amodiaquine Hydrochloride USP API on 04 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9a2507f1-3443-467a-bf8b-9d2c4c6f95ba.pdf) |
| 4 May - Anuh Pharma received WHO prequalification for Amodiaquine Hydrochloride USP API on 04 May 2026. | [Announcement Under Regulation 30 (LODR) - Updates 4 May - Anuh Pharma received WHO prequalification for Amodiaquine Hydrochloride USP API on 04 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9a2507f1-3443-467a-bf8b-9d2c4c6f95ba.pdf) |
| 30 Apr - Anuh Pharma confirms Large Corporate initial disclosure not applicable for FY 2026-27. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Anuh Pharma confirms Large Corporate initial disclosure not applicable for FY 2026-27.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/df8a505b-5b0c-4736-8514-1b57dbc47428.pdf) |
| 30 Apr - Anuh Pharma confirms Large Corporate initial disclosure not applicable for FY 2026-27. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Anuh Pharma confirms Large Corporate initial disclosure not applicable for FY 2026-27.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/df8a505b-5b0c-4736-8514-1b57dbc47428.pdf) |
| 28 Apr - Newspaper Publication for Second 100 Days Campaign - "Saksham Niveshak." | [Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Apr - Newspaper Publication for Second 100 Days Campaign - "Saksham Niveshak."](https://www.bseindia.com/xml-data/corpfiling/AttachHis/82d567be-2e37-4aef-8ad7-330b3cccad1b.pdf) |
| 28 Apr - Newspaper Publication for Second 100 Days Campaign - "Saksham Niveshak." | [Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Apr - Newspaper Publication for Second 100 Days Campaign - "Saksham Niveshak."](https://www.bseindia.com/xml-data/corpfiling/AttachLive/82d567be-2e37-4aef-8ad7-330b3cccad1b.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2015 | [Concall - Sep 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A1F34671_6E96_42FF_AB3B_E163A546B44E_115305.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9cd8b518-8788-471a-9560-fd08aa047c87.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f259f5b3-39f4-4e71-bcd0-c8625d4cfd9e.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/54ed19a8-555d-48ea-8e85-8cff1d5431dc.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b3875d3-a4b0-4679-9cf9-b0a4fc003562.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b3875d3-a4b0-4679-9cf9-b0a4fc003562.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/12d4726e-a854-4b35-9126-b199259cfd4c.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/12d4726e-a854-4b35-9126-b199259cfd4c.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3d24cdc7-ab86-4104-8bd6-4542bd315f0c.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4a571334-c387-4798-b0cc-15e89ab88fa6.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c561957c-b4c8-4a91-ad22-f104e195ca3a.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bcdc1047-50c6-45dc-98cf-96ec96cd0955.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/019a12b3-84df-465c-96d2-760257a186ce.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c7b6c274-f207-44a7-9c75-0c5f3de3dadb.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/506260/73715506260.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/506260/69081506260.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/506260/5062600320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/506260/5062600319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/506260/5062600318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/506260/5062600317.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2022-05-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a571334-c387-4798-b0cc-15e89ab88fa6.pdf) |
| 2022-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=831f6176-497a-4b33-a016-db2a96cc2446.pdf) |
| 2021-11-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54ed19a8-555d-48ea-8e85-8cff1d5431dc.pdf) |
| 2021-08-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=471c3a21-c171-4907-be1a-f9eff0dce9d7.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2022-05-30 | [Audio Recording Of The Earnings Conference Call](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77970918-d14e-423a-b422-d2d23b05639f.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:50:12.557Z.